Skip to main content

Animations

MJFF Publications

7961 - 7970 of 9030 Results
Title
Year
  • Year
  • 2018
  • 2021
  • 2023
  • 2019
  • 2014
  • 2020
  • 2018
  • 2026
  • 2020
  • 2016
  • Summary Details
    OPEN
    Title: LRRK2 activation in idiopathic Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aar5429
    Citation Count: 596
  • Summary Details
    OPEN
    Title: Reference SVA insertion polymorphisms are associated with Parkinson’s Disease progression and differential gene expression
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00189-4
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Generation of gene-corrected isogenic controls from Parkinson's disease patient iPSC lines carrying the pathogenic SNCA p.A53T variant
    Journal Name: Stem Cell Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.scr.2023.103125
    Citation Count: 4
  • Summary Details
    OPEN
    Title: mTOR hyperactivity mediates lysosomal dysfunction in Gaucher's disease iPSC-neuronal cells
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.038596
    Citation Count: 72
  • Summary Details
    OPEN
    Title: Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2013.12.011
    Citation Count: 70
  • Summary Details
    OPEN
    Title: Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.033
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Antibody biomarker for de novo Parkinson disease: attempted validation
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-018-0064-2
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Multi-cohort, cross-species urinary proteomics reveals signatures of LRRK2 dysfunction in Parkinson’s disease
    Journal Name: Molecular Systems Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s44320-026-00190-0
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Assessment of LIN28A variants in Parkinson's disease in large European cohorts
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.12.002
    Citation Count: 6
  • Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats
    2016
    Summary Details
    RESTRICTED
    Title: Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.07.025
    Citation Count: 29
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.